Vivactil or Surmontil, both tricyclic antidepressants frequently prescribed for anxiety disorders, exhibit distinct pharmacological profiles. Vivactil (nortriptyline), known for its potent blocking effects on serotonin and norepinephrine reuptake, exhibits a higher affinity for alpha-2 adrenergic receptors. This influences its potential for sedativ